Diagnostics Explores the Fragmentome
An AI-augmented blood test detects early liver fibrosis and other diseases
-
1
An AI-based liquid biopsy test detects early liver fibrosis and cirrhosis using genome-wide cell-free DNA fragmentation patterns.
-
2
The cell-free DNA fragmentome provides a noninvasive physiological snapshot of cellular states, aiding in disease identification and monitoring.
-
3
AI analyzes complex genomic data, enabling early-stage disease detection and reducing costs compared to traditional deep coverage sequencing.
-
4
The study identified over half of individuals with early liver disease and improved detection rates for advanced fibrosis and cirrhosis.
-
5
This technology has potential applications beyond liver disease, including inflammatory, vascular, neurodegenerative conditions, and various cancers.
